What's New

Article Lists Ways Researchers Can Involve People with Dementia in Identifying Research Priorities

A research article published in the Journal of the American Geriatrics Society discusses how researchers can better involve people living with FTD and other types of dementia in discussions to…

Read More about Article Lists Ways Researchers Can Involve People with Dementia in Identifying Research Priorities

Perspectives in FTD Research Webinar: FTD Research 2024 – Where We’ve Come From and Where We’re Headed

The science of FTD is evolving at a rapid pace and it can be difficult to interpret the scientific advancements and how they may impact families facing an FTD diagnosis.…

Read More about Perspectives in FTD Research Webinar: FTD Research 2024 – Where We’ve Come From and Where We’re Headed

AFTD Ambassador Advocates on Behalf of the Older Americans Act

AFTD Ambassador Judy Bearer advocated for the reauthorization of the Older Americans Act (OAA) in a December 8 opinion article published on the website Cleveland.com. Ms. Bearer, who has been…

Read More about AFTD Ambassador Advocates on Behalf of the Older Americans Act

Advancing Hope: AFTD Attends 2024 Society for Neuroscience Meeting

Dr. Nicole Bjorklund, AFTD Director of Research and Grants, and Dr. Kate Still, Research Outreach Manager, attended the Society for Neuroscience meeting in October to take in the latest research…

Read More about Advancing Hope: AFTD Attends 2024 Society for Neuroscience Meeting

New York Software Company Awards AFTD Gift to Honor Employee’s Late Cousin

AFTD has been selected as one of three organizations to receive a gift from Mindex, a software-development company in Rochester, N.Y., in honor of the latter’s 30th anniversary charity initiative.…

Read More about New York Software Company Awards AFTD Gift to Honor Employee’s Late Cousin

Transposon Presents Results from Successful Phase 2 ALS/FTD Clinical Trial

Biotechnology company Transposon Therapeutics presented the results from its successful phase 2 clinical trial of its experimental medication for ALS/FTD at the 35th International Symposium on ALS/MND. The trial of…

Read More about Transposon Presents Results from Successful Phase 2 ALS/FTD Clinical Trial

AviadoBio CEO Emphasizes Collaborative Approach for Treating FTD

In October, U.K.-based gene therapy company AviadoBio, Ltd., and pharmaceutical company Astellas announced an exclusive option and license agreement for an investigational therapeutic, AVB-101, which is currently in a Phase…

Read More about AviadoBio CEO Emphasizes Collaborative Approach for Treating FTD

January 11, 2025: In-Person Meet & Greet in Middlesex, N.J.

Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event, hosted by AFTD volunteer Norma Edom and AFTD Ambassador Sandra Gonzalez-Morett at…

Read More about January 11, 2025: In-Person Meet & Greet in Middlesex, N.J.

Dear HelpLine: Types of FTD

Dear HelpLine, My mom was recently diagnosed with FTD, and when I visited your website, I learned that there are several types of FTD. My mom wasn’t diagnosed with a…

Read More about Dear HelpLine: Types of FTD

Advancing Hope: AFTD Develops New Gene Therapy Resource

There is more hope now than ever before that researchers will be able to develop a treatment for FTD. Much research is underway to understand FTD better, treat the symptoms,…

Read More about Advancing Hope: AFTD Develops New Gene Therapy Resource